PITTSBURGH, Sept. 6, 2022 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a world pharmaceutical firm, immediately introduced the corporate will take part within the BofA World Analysis World Healthcare Convention in London on Thursday, September 15, 2022. Chief Government Officer Michael Goettler, President Rajiv Malik and Chief Monetary Officer Sanjeev Narula will signify the corporate in a hearth chat scheduled at 4:45 p.m. BST / 11:45 a.m. ET.
events can entry a reside webcast of the occasion at investor.viatris.com. An archived model additionally shall be out there following the reside occasion and could be accessed on the similar location for a restricted time.
About Viatris
Viatris Inc. (NASDAQ: VTRS), is a world pharmaceutical firm empowering folks worldwide to reside more healthy at each stage of life. We offer entry to medicines, advance sustainable operations, develop progressive options and leverage our collective experience to attach extra folks to extra services and products by way of our one-of-a-kind World Healthcare Gateway®. Fashioned in November 2020, Viatris brings collectively scientific, manufacturing and distribution experience with confirmed regulatory, medical, and industrial capabilities to ship high-quality medicines to sufferers in additional than 165 international locations and territories. Viatris’ portfolio contains greater than 1,400 authorised molecules throughout a variety of therapeutic areas, spanning each non-communicable and infectious illnesses, together with globally acknowledged manufacturers, complicated generic and branded medicines, a portfolio of biosimilars and quite a lot of over-the-counter client merchandise. With roughly 37,000 colleagues globally, Viatris is headquartered within the U.S., with world facilities in Pittsburgh, Shanghai and Hyderabad, India. Study extra at viatris.com and investor.viatris.com, and join with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
SOURCE Viatris Inc.
